Trial intelligence / Profile preview

Tacrolimus Ointment in Facial Non-segmental Vitiligo

NCT02466997Phase 3Completed

Sponsor
Centre Hospitalier Universitaire de Bordeaux
Start
Feb 2016
Primary completion
Sep 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Tacrolimus Ointment 0.1% Iwaki in Vitiligo, sponsored by Centre Hospitalier Universitaire de Bordeaux. Started Feb 2016; status: completed.

02

Drugs

Tacrolimus Ointment 0.1% Iwaki
03

Conditions

Vitiligo

Beyond the preview

Go deeper on NCT02466997.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02466997.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call